stockrowBioNTech SE Sponsored ADR (BNTX) vs BeOne Medicines Ltd. - Sponsored ADR (ONC)
- BioNTech SE Sponsored ADR BNTX 86.98 +1.30%
- BeOne Medicines Ltd. - Sponsored ADR ONC 408.03 +5.37%
BioNTech SE Sponsored ADR and BeOne Medicines Ltd. - Sponsored ADR are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $40.4B against $21.6B — 1.9× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; BeOne Medicines Ltd. - Sponsored ADR trades at 65.9×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 32.9% against −22.7%. BeOne Medicines Ltd. - Sponsored ADR has the higher net margin (13.9% vs −63.8%) and the higher return on invested capital (85.2% vs −34.3%). Across the 18 metrics below, BeOne Medicines Ltd. - Sponsored ADR leads on 14 and BioNTech SE Sponsored ADR on 4.
Valuation
Profitability
| Metric | BNTX | ONC | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.59% | 89.39% | 65.16% |
| Operating margin | (78.99%) | 17.84% | 0.00% |
| Net margin | (63.77%) | 13.86% | 0.00% |
| Free cash flow margin | (19.21%) | 21.94% | 0.00% |
| Return on equity | (8.29%) | 18.40% | (50.12%) |
| Return on assets | (7.22%) | 10.46% | (45.60%) |
| Return on invested capital | (34.28%) | 85.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack